Newmed Energ Pu (NWMD) AI Stock Analysis

• Market Cap: $18.78B
• Dividend Yield: 4.7%
• Average Volume (3M): 1.19M
• Price to Earnings (P/E): 11.1
• Beta (1Y): 1.33
• Revenue Growth: -7.79%
• EPS Growth: -4.84%
• Country: IL
• Employees: 23
• Sector: Energy
• Sector Strength: 49
• Industry: Oil & Gas Exploration & Production
• EPS (TTM): 24.80
• Shares Outstanding: 1,173,814,700
• 10 Day Avg. Volume: 1,373,624
• 30 Day Avg. Volume: 1,192,500
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: 1.24
• Enterprise Value/Revenue: 21.98
• Enterprise Value/Gross Profit: 34.95
• Enterprise Value/Ebitda: 29.67
• 1Y Price Target: $1,823.71
• Price Target Upside: 15.06% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1

• Rating: 79 Outperform
• Price Target: 1,832.00 ▲(15.58% Upside)

Newmed Energ Pu's strong financial performance, characterized by robust profitability and cash flow, is a key strength. The stock's technical indicators suggest a bullish trend, supported by attractive valuation metrics. These factors collectively contribute to a favorable overall stock score.

Newmed Energ Pu Business Overview & Revenue Model

Company Description

Newmed Energ Pu (NWMD) is a company operating in the energy sector, focusing on the development and production of natural gas resources. It is involved in the exploration, extraction, and distribution of natural gas, serving various markets with a commitment to sustainable and efficient energy solutions.

How the Company Makes Money

Newmed Energ Pu generates revenue primarily through the sale of natural gas. The company engages in long-term contracts with industrial, commercial, and residential clients to supply natural gas. Its revenue model includes direct sales, distribution partnerships, and infrastructure investments that ensure efficient delivery of natural gas to its customers. Additionally, Newmed Energ Pu may enter into joint ventures with other energy companies to optimize resource extraction and distribution, further enhancing its revenue streams. The company's earnings are significantly influenced by global gas prices, regulatory environments, and its ability to maintain strong relationships with key stakeholders in the energy market.

Newmed Energ Pu Financial Statement Overview

Summary

Newmed Energ Pu demonstrates solid financial health with strong profitability and cash flow metrics, although revenue growth has slightly declined. The balance sheet reflects a balanced leverage position with good return on equity, suggesting stability and efficient use of resources.

Income Statement

The company exhibits strong profitability with a high gross profit margin of 67.75% and a solid EBIT margin of 64.63% in TTM (Trailing-Twelve-Months). However, the revenue growth rate shows a slight decline of 1.60% from the previous year. Despite this, the net profit margin remains robust at 46.50%, indicating efficient cost management.

Balance Sheet

Newmed Energ Pu has a moderate debt-to-equity ratio of 0.86, which suggests a balanced leverage position. The equity ratio is at 45.39%, indicating a reasonable level of equity funding. Return on Equity (ROE) is strong at 28.20%, demonstrating effective use of shareholders' funds to generate profits.

Cash Flow

The company's free cash flow to net income ratio is favorable at 0.96, showing efficient conversion of profits into cash. Operating cash flow to net income ratio is also strong at 1.18, reflecting good cash generation relative to net profits. Free cash flow growth is positive at 7.76%, indicating healthy cash flow expansion.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	1.06B	1.14B	934.60M	1.14B	882.50M	587.10M
Gross Profit	664.80M	718.10M	780.70M	701.70M	518.11M	535.48M
EBITDA	783.30M	874.80M	782.70M	872.10M	633.90M	454.00M
Net Income	464.10M	524.60M	433.60M	469.70M	404.90M	365.30M
Balance Sheet
Total Assets	3.96B	3.99B	3.85B	3.94B	3.85B	4.58B
Cash, Cash Equivalents and Short-Term Investments	388.40M	384.50M	186.70M	418.30M	340.85M	239.35M
Total Debt	1.52B	1.63B	1.82B	2.16B	2.22B	3.25B
Total Liabilities	2.09B	2.21B	2.33B	2.65B	2.91B	3.59B
Stockholders Equity	1.86B	1.79B	1.51B	1.29B	938.54M	997.70M
Cash Flow
Free Cash Flow	535.60M	463.30M	423.10M	405.80M	423.25M	163.59M
Operating Cash Flow	681.40M	577.50M	559.50M	504.70M	453.64M	328.68M
Investing Cash Flow	55.20M	-114.20M	36.10M	-273.50M	982.04M	-241.82M
Financing Cash Flow	-467.40M	-441.20M	-588.90M	-429.10M	-1.29B	-187.92M

Newmed Energ Pu Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1585.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:NWMD, the sentiment is Positive. The current price of 1585 is above the 20-day moving average (MA) of 1541.37, above the 50-day MA of 1564.50, and above the 200-day MA of 1318.26, indicating a bullish trend. The MACD of 5.20 indicates Negative momentum. The RSI at 56.20 is Neutral, neither overbought nor oversold. The STOCH value of 76.09 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IL:NWMD.

Newmed Energ Pu Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
DLEKG	81 Outperform	$12.80B	11.29	10.26%	7.40%	5.86%	-3.40%
NWMD	79 Outperform	$18.78B	11.05	26.44%	4.70%	-7.79%	-4.84%
RATI	77 Outperform	$5.19B	9.78	31.13%	6.14%	―	―
TMRP	69 Neutral	3.22B	18.60		6.71%	11.84%	-4.96%
NVPT	47 Neutral	10.98B	247.91		―	-18.73%	86.94%
Sector *	45 Neutral	AU$1.31B	-11.15	-2.02%	8.53%	2.68%	-34.29%

Newmed Energ Pu Corporate Events

Newmed Energ Pu Withdraws Class Action in Settlement with Chevron

Newmed Energ Pu announced the withdrawal of a class action lawsuit against Chevron Mediterranean Limited, as part of a broader settlement negotiation. The agreement, reached with mutual consent, was filed with authorities and includes scheduled hearings to ensure compliance and implementation of the terms. The companies will continue collaborative efforts to resolve outstanding issues and maintain shareholder updates following key hearings.